Glen Eagle Advisors’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14K Sell
346
-125
-27% -$4.91K ﹤0.01% 647
2026
Q1
$17.3K Buy
471
+4
+0.9% +$154 ﹤0.01% 590
2025
Q4
$16.9K Buy
467
+5
+1% +$179 ﹤0.01% 611
2025
Q3
$16K Sell
462
-28
-6% -$921 ﹤0.01% 611
2025
Q2
$15K Buy
490
+6
+1% +$173 ﹤0.01% 591
2025
Q1
$13.8K Sell
484
-1,581
-77% -$42.5K ﹤0.01% 587
2024
Q4
$55.9K Buy
+2,065
New +$61.7K 0.01% 399

Other funds holding CTRE

Glen Eagle Advisors's CTRE Position: Q2 2026 in Review

Glen Eagle Advisors reduced its CareTrust REIT (CTRE) stake by 27% in Q2 2026, selling an estimated $4.91K and leaving 346 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Glen Eagle Advisors first reported a position in CTRE in Q4 2024 and has held it in 7 quarters since. The position peaked at $55.9K in Q4 2024. 516 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.

  • Glen Eagle Advisors held 346 shares of CareTrust REIT worth $14K as of Q2 2026.
  • Glen Eagle Advisors sold 125 CareTrust REIT shares in Q2 2026, an estimated $4.91K.
  • CareTrust REIT made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #647 holding.
  • Glen Eagle Advisors first reported a position in CareTrust REIT in Q4 2024 and has held it in 7 quarters since.
  • Glen Eagle Advisors's CareTrust REIT position peaked at $55.9K in Q4 2024.
  • 516 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.